Carmela
Gómez Rodríguez
Hospital Nacional de Parapléjicos
Toledo, EspañaHospital Nacional de Parapléjicos-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2024
-
Randomised, double-blind, placebo-controlled, parallel-group, multicentric, phase IIA clinical trial for evaluating the safety, tolerability, and therapeutic efficacy of daily oral administration of NFX88 to treat neuropathic pain in individuals with spinal cord injury
Spinal Cord, Vol. 62, Núm. 8, pp. 454-467